Mariam HAKOBYAN, from code to no-code, another idea of software
Among the entrepreneurs making a mark in 2026, we have selected the founder of Softr, Mariam Hakobyan, who did not
SAP tries to regain control of business data with DREMIO and PRIOR LABS
SAP has just sent a strong strategic signal to the enterprise software market, almost simultaneously announcing the acquisition of Dremio,
Why Jamie Foxx, Eva Longoria and Matthew McConaughey are investing in ELEVEN LABS
Jamie Foxx, Eva Longoria, Matthew McConaughey and Hwang Dong-hyuk are entering into the capital of ElevenLabs, alongside BlackRock, NVIDIA and
NELSON raises 3 million euros to structure the electrification of automobile fleets through data
The electrification of corporate automobile fleets is gradually becoming a regulatory, fiscal and environmental constraint. But behind this imperative, the
GENESIS AI wants to teach robots human gestures on a large scale
Generative artificial intelligence has profoundly transformed software by relying on models capable of generalizing cognitive tasks from massive volumes of
LIPSTIP develops an AI designed for intellectual property firms
Artificial intelligence is beginning to transform professional sectors that have long remained on the fringes of advanced digitalization. After marketing
Colossus today, orbital compute tomorrow: the long-term vision of ELON MUSK
If competition in artificial intelligence is most of the time seen through the prism of models: size of LLMs, quality
How DOCTOLIB is trying to establish itself in one of the most locked markets in Europe
With the acquisition of Medicus Health, Doctolib is not only expanding its European presence to a fifth market. The French
Letsignit appoints Amandine Fernandez as Marketing Director
Letsignit, the publisher that transforms the email signature into a real communication channel, announces the appointment of Amandine Fernandez to
Moonlight AI raises 2.8 million euros to accelerate cancer diagnosis by AI
Oncological diagnostics is gradually entering a new industrial phase, where value no longer relies solely on genetic sequencing equipment or